Aarti Drugs Quarterly Results for Trading Insights
AARTIDRUGS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹45 Cr
QSept 2025
Aarti Drugs Quarterly Results Key Highlights
- Revenue of ₹653 Cr in Sept 2025 (-3.8% vs Mar 2025, +8.8% vs Sept 2024)
- Net Profit of ₹45 Cr in Sept 2025 (-28.6% vs Mar 2025, +28.6% vs Sept 2024)
- EBITDA of ₹84 Cr in Sept 2025 (-11.6% vs Mar 2025)
- Operating Margin of 13.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹4.95 in Sept 2025 (-28.1% vs Mar 2025)
Aarti Drugs Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 653 | 679 | 591 | 603 | 600 | -3.8% | 8.8% |
| Net Profit (₹ Cr) | 45 | 63 | 54 | 41 | 35 | - | - |
| EBITDA (₹ Cr) | 84 | 95 | 74 | 56 | 69 | - | - |
| EPS (₹) | 4.95 | 6.88 | 5.91 | 4.44 | 3.83 | - | - |
| Operating Margin (%) | 13.0% | 14.0% | 13.0% | 9.0% | 11.0% | - | - |
Aarti Drugs Share Price Trend Around Quarterly Results
Visualize Aarti Drugs's 1-year price movement across quarterly results — ideal for logging trades in Aarti Drugs share price
chart using Tickjournal. All values in ₹.
Related Pages for Aarti Drugs
Additional stock information and data for AARTIDRUGS
Revenue Trend (₹ Cr)
Dec 2025
603
Jun 2025
591
Mar 2025
679
Sept 2025
653
Net Profit Trend (₹ Cr)
Dec 2025
41
Jun 2025
54
Mar 2025
63
Sept 2025
45
Operating Margin Trend (%)
Dec 2025
9.0%
Jun 2025
13.0%
Mar 2025
14.0%
Sept 2025
13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aarti Drugs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1801.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 138.6 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6071.0 | 2,860 | 689 | +7.1% | - | 24.1% | 233.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4390.0 | 3,219 | 591 | +11.3% | - | 18.4% | 250.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1292.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1314.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores